Latest News

Filters

Filter by tags: Radiopharmaceutical Clear all tag filters

29 news articles found


Orano Med (a subsidiary of the Orano Group) has laid the foundation stone for its ATLab (Alpha Therapy Laboratory) in Onnaing, France. This will be Europe's first industrial-scale pharmaceutical facility dedicated to the production of lead-212 (Pb-212) based radioligand therapies.

Date: Saturday, 10 February 2024
Original article: neimagazine.com/news/newsorano-med-breaks-ground-for-new-alpha-therapy-laboratory-11502059

Orano subsidiary Orano Med has laid the foundation stone for its Alpha Therapy Laboratory (ATLab) in Onnaing in northern France. This will be Europe's first industrial-scale pharmaceutical facility dedicated to the production of lead-212 (Pb-212) based radioligand therapies.

Date: Wednesday, 07 February 2024
Original article: world-nuclear-news.org/Articles/Construction-starts-on-French-lead-212-production

Germany-based radiopharmaceutical biotech company ITM Isotope Technologies Munich SE and Canadian Nuclear Laboratories (CNL) have launched Actineer, a joint venture for the industrial-scale production of actinium-225 (Ac-225).

Date: Friday, 20 October 2023
Original article: world-nuclear-news.org/Articles/CNL,-ITM-join-up-to-produce-rare-medical-radioisot

Kyrgyzstan's Ministry of Health and Rosatom are working together on a new nuclear medicine diagnostic centre at the National Centre for Oncology and Haematology in Bishkek, with the latest stage being the delivery of a technetium-99m GT-4K generator.

Date: Friday, 04 August 2023
Original article: world-nuclear-news.org/Articles/Nuclear-medicine-project-in-Kyrgyzstan-making-prog

US-based TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK-CEN and IBA, have launched a strategic collaboration intended to increase the availability of Actinium-225, a radioisotope used to target and treat cancer.

Date: Saturday, 01 July 2023
Original article: neimagazine.com/news/newsterrapower-and-pantera-to-collaborate-on-actinium-225-10978704

TerraPower Isotopes and Belgian joint venture PanTera have announced a collaboration to increase the global availability of actinium-225 (Ac-225), while Arizona-based Serva Energy has developed a new research reactor-based production method to ramp up the supply of the rare radioisotope.

Date: Wednesday, 28 June 2023
Original article: world-nuclear-news.org/Articles/Nuclear-innovation-companies-in-new-Ac-225-initiat

President Luis Arce Catacora has delivered the first fluorodeoxyglucose radiopharmaceuticals produced in Bolivia's new Cyclotron Preclinical Radiopharmacy Complex (CRPC) to patients of the Nuclear Medicine and Radiotherapy Centres of El Alto and Santa Cruz.

Date: Saturday, 11 March 2023
Original article: world-nuclear-news.org/Articles/Bolivia-s-first-radiopharmaceuticals-supplied

Canadian Nuclear Laboratories (CNL) is to collaborate with US-based Jubilant Radiopharma to develop alpha radiopharmaceuticals. The joint project comes under CNL’s Canadian Nuclear Research Initiative -Health (CNRI-H) programme. It is part of a broader CNL effort to develop radiopharmaceutical therapies using Actinium-225, a medical isotope produced by CNL.

Date: Wednesday, 08 February 2023
Original article: neimagazine.com/news/newscnl-and-jubilant-radiopharma-collaborate-on-actinium-225-10574940

Rosatom has begun construction of a new plant for the production of medical isotope products at the Karpov Scientific Research Institute of Physics & Chemistry in Obninsk, Kaluga region. The plant will produce a wide range of radiopharmaceuticals including those based on iodine-131, samarium-153, and molybdenum-99 isotopes. It will also develop promising active radiopharmaceuticals based on lutetium-177, actinium-225, radium-223 and other isotopes. Once completed, in 2025, it will be the largest such facility in Europe, Rosatom says. It will operate in accordance with international GMP (good manufacturing practice) standards.

Date: Friday, 27 January 2023
Original article: neimagazine.com/news/newsrosatom-begins-construction-of-radiopharmaceuticals-plant-10546229